Last Posted: Mar 08, 2020
- Exercise and Arrhythmic Risk in TMEM43 p.S358L Arrhythmogenic Right Ventricular Cardiomyopathy.
Paulin Frédéric L, et al. Heart rhythm 2020 2 - Cardiac Phenotypes, Genetics, and Risks in Familial Noncompaction Cardiomyopathy.
van Waning Jaap I et al. Journal of the American College of Cardiology 2019 73(13) 1601-1611 - Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy.
Mazzarotto Francesco et al. Cardiovascular drugs and therapy 2020 Feb - Therapeutic genome editing in cardiovascular diseases.
Nishiga Masataka et al. Advanced drug delivery reviews 2020 Feb - Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers.
Chaves-Markman Ândrea et al. Cureus 2020 Jan 12(1) e6530 - Correction: Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy.
Esslinger Ulrike, et al. PloS one 2020 0 (2) e0229472 - Genetic screening for hypertrophic cardiomyopathy in large, asymptomatic military cohorts.
Brough Joe et al. American journal of medical genetics. Part C, Seminars in medical genetics 2020 Feb - Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy.
Belmonte Thalía et al. Translational research : the journal of laboratory and clinical medicine 2020 Jan - Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging.
Muresan Ioana Danuta et al. Heart failure reviews 2020 Feb - The Cardiac Genome Clinic: implementing genome sequencing in pediatric heart disease.
Reuter Miriam S et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Feb
.png)
No hay comentarios:
Publicar un comentario